Munson's sign
Munson's sign is a clinical sign often associated with keratoconus, a degenerative disorder of the eye. It is characterized by a V-shaped indentation of the lower eyelid when the patient looks downwards. This sign is named after Dr. Edward Jackson Munson, an American ophthalmologist who first described it in 1927.
Overview
Keratoconus is a non-inflammatory eye condition in which the normally round dome-shaped cornea progressively thins causing a cone-like bulge to develop. This results in significant visual impairment. Munson's sign is one of the clinical signs that can be observed in patients with this condition.
Clinical Significance
Munson's sign is a diagnostic sign of keratoconus. It is observed when the patient is asked to look down, and a V-shaped indentation of the lower eyelid can be seen. This is due to the protrusion of the cornea which pushes the lower eyelid outwards.
However, it is important to note that not all patients with keratoconus will exhibit Munson's sign. It is typically seen in advanced cases of the disease.
Diagnosis
The diagnosis of keratoconus is typically made through a comprehensive eye examination. This may include a review of the patient's medical history, visual acuity testing, and corneal mapping. The presence of Munson's sign can aid in the diagnosis, but it is not the only diagnostic criterion.
Treatment
The treatment for keratoconus depends on the severity of the condition. In the early stages, eyeglasses or soft contact lenses may be used to correct the vision. As the disease progresses, rigid gas permeable (RGP) contact lenses, "piggybacking" contact lenses, or scleral contact lenses may be required. In severe cases, corneal transplantation may be necessary.
See Also
References
- Munson, E. J. (1927). Keratoconus. American Journal of Ophthalmology, 10(6), 725-738.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


